McKesson, which owns large oncology practice US Oncology, is buying two more firms in the oncology space for $1.2 billion: Biologics, a cancer specialty pharmacy; and Vantage Oncology, a radiation and other therapy provider.
McKesson, which owns large oncology practice US Oncology, is buying two more firms in the oncology space for $1.2 billion: Biologics, a cancer specialty pharmacy; and Vantage Oncology, a radiation and other therapy provider.
© 2025 Healthy Skeptic.
